...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Chinese journal of digestive diseases >Intestinal microflora in patients with liver cirrhosis
【24h】

Intestinal microflora in patients with liver cirrhosis

机译：肝硬化患者的肠道菌群

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: Patients with liver cirrhosis have varying degrees of imbalance of the intestinal flora and probiotics can improve some of the symptoms of gastrointestinal dysfunction in these patients. In the present study, blood ammonia, fecal pH, fecal ammonia, and plasma endotoxin were measured after administration of two kinds of probiotics in order to detect the changes in intestinal flora.METHODS: Six bacteria and yeast were cultured and the colony forming units were counted. Fifty cirrhotic patients were randomized to receive probiotic capsules containing Bifidobacterium, Lactobacillus acidophilus and Enterococcus, or probiotic capsules containing Bacillus subtilis and Enterococcus faecium for 14 days. Fecal flora, pH and ammonia, blood ammonia (detected by test paper) and plasma endotoxin (detected by LAL test kits) were measured before and after the treatment.
机译：目的：肝硬化患者的肠道菌群失衡程度不同，益生菌可以改善这些患者的胃肠功能障碍症状。本研究通过两种益生菌给药后测定血氨，粪便pH，粪便氨和血浆内毒素，以检测肠道菌群的变化。方法：培养六种细菌和酵母菌，菌落形成单位为算了。五十名肝硬化患者被随机分配接受双歧杆菌，嗜酸乳杆菌和肠球菌的益生菌胶囊，或接受枯草芽孢杆菌和粪肠球菌的益生菌胶囊，持续14天。在治疗前后分别测量粪便菌群，pH和氨，血氨（通过试纸检测）和血浆内毒素（通过LAL测试盒检测）。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号